Fig. 1 | British Journal of Cancer

Fig. 1

From: Platinum response characteristics of patients with pancreatic ductal adenocarcinoma and a germline BRCA1, BRCA2 or PALB2 mutation

Fig. 1

Best Objective Response to Platinum Based Treatment. Waterfall plots showing best percentage change in target-lesion size from time of initiation of platinum-based therapy. a Best overall change in tumour size in control patients. For the control cohort, 13 patients were not included due to undefined change in tumour size. b Best overall change in tumour size in mut-positive patients. For the mut-positive cohort, two patients were not included due to undefined change in tumour size. The upper dashed line indicates a 20% increase in tumour size and the lower dashed line indicates a 30% reduction in tumour size

Back to article page